Absci ABSI
NASDAQ ABSI
$10.91 +0.16 (+1.52%)
As of: Oct 2, 2026 · 1:07 PM EDT

Absci (ABSI) Non-Current Deffered Revenue (2021 - 2026)

Updated

Absci (ABSI) recorded Non-Current Deffered Revenue of $240,000 in Q2 2026, down 62.6% from the prior quarter.

Analysis

Absci (ABSI) Non-Current Deffered Revenue (2021 - 2026) Analysis & Trends

At the end of FY2025, Absci reported Non-Current Deffered Revenue of $436,000.

  • Across earlier years, Non-Current Deffered Revenue came in at $966,000 in FY2023.
  • The Q2 2026 figure is the lowest quarterly Non-Current Deffered Revenue since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Absci 1.85 Bn 1.22 Bn - 240,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 240,000.00
Mar 31, 2026 641,000.00
Dec 31, 2025 436,000.00
Mar 31, 2024 180,000.00
Dec 31, 2023 966,000.00
Sep 30, 2021 122,000.00
Jun 30, 2021 839,000.00
API Access

Absci Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ABSI&period=max&api_key=YOUR_API_KEY